Regulation of tumor–stroma interactions by the unfolded protein response

The unfolded protein response (UPR) is a conserved adaptive pathway that helps cells cope with the protein misfolding burden within the endoplasmic reticulum (ER). Imbalance between protein folding demand and capacity in the ER leads to a situation called ER stress that is often observed in highly p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FEBS journal 2019-01, Vol.286 (2), p.279-296
Hauptverfasser: Obacz, Joanna, Avril, Tony, Rubio‐Patiño, Camila, Bossowski, Jozef P., Igbaria, Aeid, Ricci, Jean‐Ehrland, Chevet, Eric
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The unfolded protein response (UPR) is a conserved adaptive pathway that helps cells cope with the protein misfolding burden within the endoplasmic reticulum (ER). Imbalance between protein folding demand and capacity in the ER leads to a situation called ER stress that is often observed in highly proliferative and secretory tumor cells. As such, activation of the UPR signaling has emerged as a key adaptive mechanism promoting cancer progression. It is becoming widely acknowledged that, in addition to its intrinsic effect on tumor biology, the UPR can also regulate tumor microenvironment. In this review, we discuss how the UPR coordinates the crosstalk between tumor and stromal cells, such as endothelial cells, normal parenchymal cells, and immune cells. In addition, we further describe the involvement of ER stress signaling in the response to current treatments as well as its impact on antitumor immunity mainly driven by immunogenic cell death. Finally, in this context, we discuss the relevance of targeting ER stress/UPR signaling as a potential anticancer approach. The unfolded protein response (UPR) that is often deregulated in tumor cells has emerged as a regulator of cancer hallmarks. Here, we provide a comprehensive review on how UPR activation in cancer and stromal cells orchestrates tumor microenvironment to support disease progression and chemoresistance or to trigger the anti‐tumor immune response.
ISSN:1742-464X
1742-4658
DOI:10.1111/febs.14359